Sativex multiple sclerosis drug. Patient holding a Sativex spray. This cannabinoid oromucosal mouth spray was developed by GW Pharmaceuticals for multiple sclerosis patients. It is used to alleviate neuropathic pain,spasticity,overactive bladder,and other symptoms. It is also being trialled as a pain control drug for cancer patients | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Thomas, Mark |
Bildgröße: | 3413 px × 5144 px |
Modell-Rechte: | nicht erforderlich |
Restrictions: | - |